|
|
Drug Discovery Market Research
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Drug Discovery Market, including, but not limited to latest business trend on : Drug Discovery; Target Quest; Target Validation; Lead Optimization; Pharmacology; ADMET; Pharmacogenomics; Metabonomics.
We offer market research, industry forecasts, and business analysis in the Drug Discovery Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
Reports
| Biochip Trends for Drug R&D and Diagnostics - Companies, Equipment, Consumables, Software, Services and World Market |
|
| Published : 2008/04 |
| This report discusses new biochip products now reaching the market. DNA/ RNA products discussed include high-density tiling, copy number variation, SNPs, alternate splice variant, ChIP-Chip, CpG island, DNA methylation, microRNA, molecular diagnostic bioc ... |
| Addressing Key Challenges in Drug Safety (Strategic Focus) |
|
| Published : 2008/03 |
| High profile drug withdrawals and negative public attention has placed drug safety at the top of the pharmaceutical industry' s agenda. This report will examine pharmacovigilance technology solutions designed to alleviate the challenges in drug safety man ... |
| Bigpharma Partnering Agreements |
|
| Published : 2008/03 |
| The Bigpharma Partnering Agreements provides comprehensive and unprecedented access to the partnering agreements entered into by the worlds leading fifty biopharma companies. ... |
| Rheumatoid Arthritis Drug Discoveries: what the future holds |
|
| Published : 2008/03 |
| This new management report provides a complete examination of the RA market and its prospects in the medium term. Packed with analysis and forecasts, anyone needing to understand the drivers of this fast growing sector need look no further. ... |
| Antibiotics and Drug Resistance 2008 |
|
| Published : 2008/01 |
| This report reviews new drug innovation and strategy to combat antibiotic resistance mechanisms. This embraces current research-stage activities, patents published in the last five years, the entire pharmaceutical development pipeline and today' s existin ... |
| Emerging Drug Targets in Alzheimer's Disease |
|
| Published : 2007/12 |
| The lack of effective treatments for Alzheimer' s disease (AD) and an aging population create an enormous opportunity for disease-modifying drugs. Competition to develop new drugs for AD is in fact fi erce, and the effi cacy bar for current AD therapies i ... |
| Antibody Drug Targets and Focus on Breast- & Prostate Cancer |
|
| Published : 2007/11 |
| In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Antibody drug target, Breast- and Prostate cancer, which are all subjects to an extensive number of innovative drug candidates. This extensive 380 ... |
| Drug Discovery Technologies |
|
| Published : 2007/11 |
| This study examines trends in drug discovery. Drug discovery is an enormous field, and this report focuses on a selection of the major workhorse technologies, including liquid chromatography and mass spectrometry, as well as on newer approaches, such as s ... |
| Synthetic Biology: An Emerging Tool for Drug Discovery and Production |
|
| Published : 2007/10 |
| Lying at the interface of biology and engineering, synthetic biology represents a new discipline emphasizing an engineering approach to building biological systems from components. Already, simple synthetic devices such as biological clocks have been crea ... |
| Drug Repositioning Strategies for Refueling the Pipeline |
|
| Published : 2007/05 |
| Drug companies have historically found new indications for their existing drugs serendipitously. Now, however, to refuel product pipelines and improve profi t margins, many companies are turning to low-risk strategies such as drug repositioning. ... |
| Drug Treatments for Leading Endocrine and Metabolic Diseases |
|
| Published : 2007/02 |
| The aim of this report is to provide a range of information - from detailed market analyses through industry trends - to quantify, qualify, and compare prescription products on the market and in development for the treatment of selected endocrine and meta ... |
| Chemical Genetics in Drug Discovery |
|
| Published : 2006/11 |
| In the drive to streamline the drug discovery process, biotechnology and pharmaceutical companies are harnessing chemical genetics as a tool to overcome the limitations of traditional target-based drug discovery. ... |
| CNS Drug Discoveries: Depression Chapter |
|
| Published : 2006/11 |
| The market for antidepressive drugs is the largest segment of the CNS sector with global sales of US$16.2 billion in 2005. Find out more in this chapter of CNS Drug Discoveries. ... |
| CNS Drug Discoveries: Multiple Sclerosis Chapter |
|
| Published : 2006/11 |
| The incidence of multiple sclerosis varies throughout the world, although there is a significantly higher incidence of the disease found in the Northern Hemisphere. Find out more in this chapter of CNS Drug Discoveries. ... |
| CNS Drug Discoveries: Schizophrenia Chapter |
|
| Published : 2006/11 |
| The antipsychotic market generated global sales of US$15.5 billion, accounting for 23% of global CNS sales in 2005. This chapter of CNS Drug Discoveries focuses on schizophrenia. ... |
| World Drug Discovery Technologies Markets Outlook |
|
| Published : 2006/11 |
| This study focuses on the market dynamics of 2005, by looking at the four major contributors to this market: top 20 pharmaceutical companies, biotechnology companies, top 5 agribiotech companies, and the NIH budget. ... |
| Kinases: Advanced Strategies and Multiple Targets for Drug Discovery |
|
| Published : 2006/09 |
| D&MD's Kinases: Advanced Strategies for Drug Discovery market analysis report comprehensively reviews protein kinases and assesses their importance as drug targets. Approaches to kinase drug discovery are evolving. Small molecule inhibitors now encompass ... |
| Big Pharma Embraces Pharmacogenomics - But Are We There Yet? |
|
| Published : 2006/08 |
| Pharmacogenomics will revolutionize the drug industry by linking the right drug to the right patient. Several companies and regulatory agencies are leading the charge to implement this approach of developing targeted medicines. ... |
| Contract Research Organisation (CRO) Markets in Europe |
|
| Published : 2006/08 |
| This analysis is available through our Drug Discovery Technologies Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive featur ... |
| Drug Discovery Technologies |
|
| Published : 2006/07 |
| This report analyzes the worldwide markets for Drug Discovery Technologies in Millions of US$. ... |
| European POCT Markets |
|
| Published : 2006/07 |
| This analysis is available through our Drug Discovery Technologies Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive featur ... |
Annual Information Services
| Pharmaceuticals & Healthcare Country Reports for 24 European Markets |
|
| Issues / Year : 96 |
| Each BMI Pharmaceutical and Healthcare industry report has been researched at source and features the latest available data and forecasts to 2012 covering drugs and healthcare expenditure, the prescription, OTC and generics markets, and foreign trade; com ... |
|
|
View Cart
